PHIA logo

Koninklijke Philips N.V. Stock Price

ENXTAM:PHIA Community·€22.6b Market Cap
  • 3 Narratives written by author
  • 0 Comments on narratives written by author
  • 80 Fair Values set on narratives written by author

PHIA Share Price Performance

€23.72
-0.17 (-0.71%)
€34.38
Fair Value
€23.72
-0.17 (-0.71%)
31.0% undervalued intrinsic discount
€34.38
Fair Value
Price €23.72
AnalystHighTarget €34.38
AnalystConsensusTarget €26.68
AnalystLowTarget €19.60

PHIA Community Narratives

AnalystHighTarget·
Fair Value €34.38 31.0% undervalued intrinsic discount

AI Hospital Platforms And Productivity Programs Will Transform This Healthcare Leader

0users have liked this narrative
0users have commented on this narrative
4users have followed this narrative
AnalystConsensusTarget·
Fair Value €26.68 11.1% undervalued intrinsic discount

AI-Enabled Healthcare Demand And Chronic Care Trends Will Drive Long-Term Upside

0users have liked this narrative
0users have commented on this narrative
3users have followed this narrative
AnalystLowTarget·
Fair Value €19.6 21.0% overvalued intrinsic discount

Trade Barriers And Regulatory Costs Will Cap Margins And Pressure Long Term Prospects

0users have liked this narrative
0users have commented on this narrative
2users have followed this narrative
€34.38
31.0% undervalued intrinsic discount
Revenue
6.28% p.a.
Profit Margin
7.34%
Future PE
27.42x
Price in 2029
€41.56
€26.68
11.1% undervalued intrinsic discount
Revenue
3.4% p.a.
Profit Margin
7.37%
Future PE
23.07x
Price in 2028
€32.32
€19.6
21.0% overvalued intrinsic discount
Revenue
2.49% p.a.
Profit Margin
7.58%
Future PE
16.89x
Price in 2028
€23.73

Trending Discussion

Updated Narratives

PHIA logo

AI Hospital Platforms And Productivity Programs Will Transform This Healthcare Leader

Fair Value: €34.38 31.0% undervalued intrinsic discount
4 users have followed this narrative
0 users have commented on this narrative
0 users have liked this narrative
PHIA logo

AI-Enabled Healthcare Demand And Chronic Care Trends Will Drive Long-Term Upside

Fair Value: €26.68 11.1% undervalued intrinsic discount
3 users have followed this narrative
0 users have commented on this narrative
0 users have liked this narrative
PHIA logo

Trade Barriers And Regulatory Costs Will Cap Margins And Pressure Long Term Prospects

Fair Value: €19.6 21.0% overvalued intrinsic discount
2 users have followed this narrative
0 users have commented on this narrative
0 users have liked this narrative

Snowflake Analysis

Good value with adequate balance sheet.

1 Risk
4 Rewards

Koninklijke Philips N.V. Key Details

€17.8b

Revenue

€9.8b

Cost of Revenue

€8.1b

Gross Profit

€7.2b

Other Expenses

€899.0m

Earnings

Last Reported Earnings
Dec 31, 2025
Next Reporting Earnings
May 06, 2026
0.95
45.18%
5.04%
64.8%
View Full Analysis

About PHIA

Founded
1891
Employees
61085
CEO
Roy W. Jakobs
WebsiteView website
www.philips.com

Koninklijke Philips N.V. operates as a health technology company in North America, the Greater China, and internationally. It operates through Diagnosis & Treatment, Connected Care, and Personal Health segments. The company provides diagnostic imaging solutions, includes ultrasound business unit, magnetic resonance imaging, computed tomography, and diagnostic x-ray; Image Guided Therapy, including image guided therapy systems and image guided therapy devices. It also offers monitoring, enterprise informatics, and sleep and respiratory care, as well as personal health. The company was formerly known as Koninklijke Philips Electronics N.V. and changed its name to Koninklijke Philips N.V. in May 2013. Koninklijke Philips N.V. was founded in 1891 and is headquartered in Amsterdam, the Netherlands.

Recent PHIA News & Updates

Recent updates

No updates

Koninklijke Philips N.V. Competitors